211 related articles for article (PubMed ID: 19667040)
1. Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy.
Holmer H; Ekman B; Björk J; Nordstöm CH; Popovic V; Siversson A; Erfurth EM
Eur J Endocrinol; 2009 Nov; 161(5):671-9. PubMed ID: 19667040
[TBL] [Abstract][Full Text] [Related]
2. Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma.
Holmer H; Pozarek G; Wirfält E; Popovic V; Ekman B; Björk J; Erfurth EM
J Clin Endocrinol Metab; 2010 Dec; 95(12):5395-402. PubMed ID: 20826582
[TBL] [Abstract][Full Text] [Related]
3. Hypothalamic involvement and insufficient sex steroid supplementation are associated with low bone mineral density in women with childhood onset craniopharyngioma.
Holmer H; Popovic V; Ekman B; Follin C; Siversson AB; Erfurth EM
Eur J Endocrinol; 2011 Jul; 165(1):25-31. PubMed ID: 21502326
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction.
Yuen KC; Koltowska-Häggström M; Cook DM; Fox JL; Jönsson PJ; Geffner ME; Abs R
Eur J Endocrinol; 2013 Oct; 169(4):511-9. PubMed ID: 23904277
[TBL] [Abstract][Full Text] [Related]
5. Long-term Effects of Growth Hormone Replacement Therapy in Childhood-onset Craniopharyngioma: Results of the German Craniopharyngioma Registry (HIT-Endo).
Boekhoff S; Bogusz A; Sterkenburg AS; Eveslage M; Müller HL
Eur J Endocrinol; 2018 Oct; 179(5):331-341. PubMed ID: 30139824
[TBL] [Abstract][Full Text] [Related]
6. Hypothalamic involvement predicts cognitive performance and psychosocial health in long-term survivors of childhood craniopharyngioma.
Fjalldal S; Holmer H; Rylander L; Elfving M; Ekman B; Osterberg K; Erfurth EM
J Clin Endocrinol Metab; 2013 Aug; 98(8):3253-62. PubMed ID: 23771923
[TBL] [Abstract][Full Text] [Related]
7. Impaired aerobic exercise adaptation in children and adolescents with craniopharyngioma is associated with hypothalamic involvement.
Piguel X; Abraham P; Bouhours-Nouet N; Gatelais F; Dufresne S; Rouleau S; Coutant R
Eur J Endocrinol; 2012 Feb; 166(2):215-22. PubMed ID: 22096113
[TBL] [Abstract][Full Text] [Related]
8. GHRH plus arginine in the diagnosis of acquired GH deficiency of childhood-onset.
Maghnie M; Cavigioli F; Tinelli C; Autelli M; Aricò M; Aimaretti G; Ghigo E
J Clin Endocrinol Metab; 2002 Jun; 87(6):2740-4. PubMed ID: 12050243
[TBL] [Abstract][Full Text] [Related]
9. Hypopituitarism oddities: craniopharyngiomas.
Karavitaki N
Horm Res; 2007; 68 Suppl 5():151-3. PubMed ID: 18174734
[TBL] [Abstract][Full Text] [Related]
10. The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma.
Kendall-Taylor P; Jönsson PJ; Abs R; Erfurth EM; Koltowska-Häggström M; Price DA; Verhelst J
Eur J Endocrinol; 2005 Apr; 152(4):557-67. PubMed ID: 15817911
[TBL] [Abstract][Full Text] [Related]
11. Discontinuation of growth hormone (GH) treatment during the transition phase is an important factor determining the phenotype of young adults with nonidiopathic childhood-onset GH deficiency.
Kołtowska-Häggström M; Geffner ME; Jönsson P; Monson JP; Abs R; Hána V; Höybye C; Wollmann HA
J Clin Endocrinol Metab; 2010 Jun; 95(6):2646-54. PubMed ID: 20335451
[TBL] [Abstract][Full Text] [Related]
12. Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index.
Trivin C; Busiah K; Mahlaoui N; Recasens C; Souberbielle JC; Zerah M; Sainte-Rose C; Brauner R
BMC Pediatr; 2009 Apr; 9():24. PubMed ID: 19341477
[TBL] [Abstract][Full Text] [Related]
13. Relative Risks of Contributing Factors to Morbidity and Mortality in Adults With Craniopharyngioma on Growth Hormone Replacement.
Yuen KCJ; Mattsson AF; Burman P; Erfurth EM; Camacho-Hubner C; Fox JL; Verhelst J; Geffner ME; Abs R
J Clin Endocrinol Metab; 2018 Feb; 103(2):768-777. PubMed ID: 29029108
[TBL] [Abstract][Full Text] [Related]
14. Patients with craniopharyngiomas: therapeutical difficulties with growth hormone.
Cannavò S; Marini F; Trimarchi F
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):56-60. PubMed ID: 19020388
[TBL] [Abstract][Full Text] [Related]
15. Nuchal Skinfold Thickness: A Novel Parameter for Assessment of Body Composition in Childhood Craniopharyngioma.
Sterkenburg AS; Hoffmann A; Reichel J; Lohle K; Eveslage M; Warmuth-Metz M; Müller HL
J Clin Endocrinol Metab; 2016 Dec; 101(12):4922-4930. PubMed ID: 27680877
[TBL] [Abstract][Full Text] [Related]
16. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
Feldt-Rasmussen U; Wilton P; Jonsson P; ;
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
[TBL] [Abstract][Full Text] [Related]
17. Analysis of short- and long-term metabolic effects of growth hormone replacement therapy in adult patients with craniopharyngioma and non-functioning pituitary adenoma.
Profka E; Giavoli C; Bergamaschi S; Ferrante E; Malchiodi E; Sala E; Verrua E; Rodari G; Filopanti M; Beck-Peccoz P; Spada A
J Endocrinol Invest; 2015 Apr; 38(4):413-20. PubMed ID: 25330765
[TBL] [Abstract][Full Text] [Related]
18. Features of the metabolic syndrome after childhood craniopharyngioma.
Srinivasan S; Ogle GD; Garnett SP; Briody JN; Lee JW; Cowell CT
J Clin Endocrinol Metab; 2004 Jan; 89(1):81-6. PubMed ID: 14715831
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging-graded hypothalamic compression in surgically treated adult craniopharyngiomas determining postoperative obesity.
Van Gompel JJ; Nippoldt TB; Higgins DM; Meyer FB
Neurosurg Focus; 2010 Apr; 28(4):E3. PubMed ID: 20367360
[TBL] [Abstract][Full Text] [Related]
20. Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up.
Olsson DS; Buchfelder M; Wiendieck K; Kremenevskaja N; Bengtsson BÅ; Jakobsson KE; Jarfelt M; Johannsson G; Nilsson AG
Eur J Endocrinol; 2012 Jun; 166(6):1061-8. PubMed ID: 22457235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
